At 09:45 hrs Dr Reddys Laboratories was quoting at Rs 1,770, up Rs 12.65, or 0.72%. It has touched an intraday high of Rs 1,774.80 and an intraday low of Rs 1,750.
It was trading with volumes of 1,704 shares. In the previous trading session, the share closed up 1.83% or Rs 31.55 at Rs 1,757.35.
The company's trailing 12-month (TTM) EPS was at Rs 51.10 per share. (Sep, 2012). The stock's price-to-earnings (P/E) ratio was 34.64. The latest book value of the company is Rs 395.56 per share. At current value, the price-to-book value of the company was 4.47. The dividend yield of the company was 0.78%.
The share touched its 52-week high Rs 1,818 and 52-week low Rs 1,558.55 on 20 April, 2012 and 23 November, 2011, respectively.
Currently, it is trading 2.64% below its 52-week high and 13.57% above its 52-week low.
Market capitalisation stands at Rs 30,060.62 crore.
Anda sedang membaca artikel tentang
Dr Reddys launches generic Revatio tablets in US; stk up
Dengan url
https://olahragakecantikan.blogspot.com/2012/11/dr-reddys-launches-generic-revatio.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Dr Reddys launches generic Revatio tablets in US; stk up
namun jangan lupa untuk meletakkan link
Dr Reddys launches generic Revatio tablets in US; stk up
sebagai sumbernya
0 komentar:
Posting Komentar